Previous close | 92.60 |
Open | 94.24 |
Bid | 91.34 x 900 |
Ask | 105.00 x 1000 |
Day's range | 92.57 - 96.38 |
52-week range | 70.74 - 97.13 |
Volume | |
Avg. volume | 472,427 |
Market cap | 4.868B |
Beta (5Y monthly) | 0.33 |
PE ratio (TTM) | 38.97 |
EPS (TTM) | 2.46 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 105.57 |
Haemonetics Corporation (NYSE:HAE) Q4 2024 Earnings Call Transcript May 10, 2024 Haemonetics Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. Welcome to the Q4 2024 Haemonetics Corporation Earnings Conference Call. At […]
Comprehensive Analysis of Haemonetics' Latest Financial Performance and Future Outlook
Haemonetics (HAE) Q4 revenues were driven by an uptick in the Plasma and Hospital segments.